Affymetrix Inc. (AFFX) Launches Customizable Genotype Technology

QualityStocks would like to highlight Affymetrix (NASDAQ: AFFX). The company’s technology is used by the world's top pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and nonprofit research institutes. The company is adding new genetic analysis technologies to streamline workflows and help revolutionize life.

In the company’s news today,

Affymetrix has rolled-out its Axiom myDesign Targeted Genotyping Arrays to help researchers study disease mutations and characterize gene-gene interactions.

The technology provides researchers the ability to design custom arrays to genotype 1,500 to 2.6 million markers per sample; from there, researchers can transition from genome-wide scans to zero-in on specific analyses using various approaches on the same platform.

“Axiom myDesign TG Arrays will help researchers to quickly evaluate interesting variants from their GWAS, sequencing and candidate gene initiatives without limiting the number of markers in their study,” Andy Last, chief commercial officer of Affymetrix stated in the press release. “Customers who want to add newly discovered content after they complete the initial design can benefit from our new flexible content capability without switching platforms.”

Affymetrix also announced the launch of a new version of the Axiom Genomic Database, which contains 11 million variants. By expanding the scale of the database, the company offers a customizable genotyping solution that can alleviate budget restrictions and create a more streamlined work flow.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.